-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
January 09, 2020 - ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks
None
7
PICOTS
Elements
Inclusion Criteria Exclusion
Criteria … ; 2 weeks to 4 weeks), patient demographics (e.g. age, race, ethnicity, gender,
socioeconomic status
-
www.ahrq.gov/practiceimprovement/systemdesign/leancasestudies/lean-exhibit2-8.html
November 01, 2014 - Duration: Short sessions 1 to 2 weeks prior to RCI event and 5-day RCI.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - Placebo (N=323;
12 weeks Fesoterodine vs. … Placebo (n=352;
dose: NA)
12 weeks OTG vs. … PFMT (n=
50; twice/day for 15
minutes each, for 12
weeks)
12 weeks APFMT vs. … PFTM
(n=15; twice-weekly
sessions of 40 min for
6 weeks); control
(n=15; dose: NA)
6 weeks Urinary … , for 4
weeks plus two
additional sessions, 3
weeks apart)
12 weeks Paula Method (Circular Muscle
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - x 12
weeks
Measures of inflammation
included CRP and ESR. … x 12
weeks
12 weeks- 64/75 (85%) of
tocilizumab group vs 9/37 (24%)
placebo [P<0.001].
52 weeks … Remission was recorded
in 25% after 24 weeks, 52% after
48 weeks, 75% after 72 weeks,
and 98% after … x 12
weeks
12 weeks- 64/75 (85%) of
tocilizumab group vs 9/37 (24%)
placebo [P<0.001].
52 weeks … (13
weeks, 95% CI 6-20) or MTX (6
weeks, 95% CI 2-10)
Author, year Trial n Subjects Primary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - x 12
weeks
Measures of inflammation
included CRP and ESR. … x 12
weeks
12 weeks- 64/75 (85%) of
tocilizumab group vs 9/37 (24%)
placebo [P<0.001].
52 weeks … Remission was recorded
in 25% after 24 weeks, 52% after
48 weeks, 75% after 72 weeks,
and 98% after … x 12
weeks
12 weeks- 64/75 (85%) of
tocilizumab group vs 9/37 (24%)
placebo [P<0.001].
52 weeks … (13
weeks, 95% CI 6-20) or MTX (6
weeks, 95% CI 2-10)
Author, year Trial n Subjects Primary
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/pruprev/7.html
December 01, 2017 - Report Description
This report displays 4 weeks of clinical data for a single resident that is captured … This report assumes the EMR vendor can display data for multiple weeks using multiple data sources.
-
hcup-us.ahrq.gov/reports/statbriefs/sb267-Hurricanes-Injuries-ED-Visits-2005-2016.pdf
January 01, 2016 - The
prehurricane rate was calculated as an average during the 4 weeks immediately preceding the hurricane … (1, 2, and 3 weeks posthurricane). … Posthurricane
3 Weeks Posthurricane
Near path
Remote
Treat-and-Release ED VisitsDirect path
5 … Posthurricane
3 Weeks Posthurricane
Near path
Remote
Direct path ED Visits Resulting in Admission … For children
aged 0–17 years, the rate increased in the week of the hurricane and the first 2 weeks
-
psnet.ahrq.gov/node/50929/psn-pdf
February 26, 2020 - with follow up in the Orthopedics clinic in two weeks and in
the Infectious Diseases clinic in three … weeks. … The patient was seen in the Orthopedics clinic 3.5 weeks
after discharge, still on intravenous antibiotics … the discharge orders to
schedule a follow-up appointment in the Infectious Diseases clinic in three weeks … , the patient was not seen
there until five weeks after discharge.
-
www.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/other-resources.html
September 01, 2021 - disorders: Psychotherapy (e.g., Parent management training, parent child interaction therapy) x 10-20 weeks … sessions
C (Preschool)
A (6-18yrs)
Anxiety (GAD, SAD, SM, SP): CBT is first line, x 12 weeks … PTSD: Psychotherapy is first line (Child Parent Psychotherapy x six months minimum; or CBT x 12 weeks … Play therapy)
A (6-18yrs, CBT)
OCD: CBT with parent involvement, behavioral therapy x 12 weeks … Table: Fasting plasma glucose – Baseline, 12 weeks, annually; Fasting lipid profile – Baseline, 12 weeks
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/pruprev/exercises6.html
December 01, 2017 - Is the dietitian aware of the steady decline in meal intake over the past 4 weeks? … Is the dietitian aware of the poor meal intake over the past 4 weeks? … Is the dietitian aware of the decline in meal intake over the past 4 weeks?
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/588/gdart/pdf
May 01, 2008 - A) After 24 weeks’ gestation? B) During the first
trimester and up to 24 weeks’ gestation?
2. … A) After 24 weeks’
gestation? B) During the first trimester and up to 24 weeks’ gestation? … A) After 24 weeks’ gestation? B) During the first trimester and up to 24 weeks’ gestation? … A) After 24 weeks’ gestation? B) During the first trimester
and up to 24 weeks’ gestation? … After 24 weeks’ gestation?
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/booklets/gallbladder-booklet.pdf
November 01, 2023 - You may feel bloated or have
gas or diarrhea for a few weeks or months. … It may be a few days or many weeks. … In the weeks after surgery:
■ Avoid soda and fizzy drinks. These can cause gas. … Possible Weight Loss
Sometimes people lose 10 to 15 pounds in the weeks after surgery. … F Do NOT smoke, vape, or chew tobacco for at least 4 weeks.
-
digital.ahrq.gov/health-it-tools-and-resources/implementation-toolsets-e-prescribing/toolset-e-prescribing/tool-71-timeline-stand-alone-e-prescribing-implementation
January 01, 2023 - to implementation manager:
process assessment summary
completed registration forms
Weeks … training (1-3 days)
Make daily support calls for first week
Make weekly support calls for next 3 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
January 01, 2019 - B
Hyperglycemia (minor event): 0% vs. 3.3% (1/30) NR NR NR
Authors report no COI Moderate 2 weeks
1 … B
Any AE: 0% vs. 0% NR NR NR High 1 day
2 days
1 week
2 weeks
1 month
12 months Patient satisfaction … CLBP of confirmed facet origin NR NR >6 weeks required for inclusion NR
Authors state no difference … syndrome NR 0% (exclusion criteria) 4.3 years 64 82% 29 NR Hypertension: 15% 12 weeks, 24 weeks A vs … B
Repeat injection, % (n/N)
3 weeks
40% (80/195) vs. 37.5% (75/189) Allowed to crossover at 6 weeks.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/pruprev/addexercises.pdf
August 08, 2025 - The 38% weekly average meal intake value seems odd for 2 weeks ago. … Viewing the trends over the last 4 weeks, which category has:2. … • Shown no improvement over 4 weeks?
• The most fluctuation week to week? … Is the dietitian aware of the poor meal intake over the past 4 weeks? … Is the dietitian aware of the decline in meal intake over the past 4 weeks?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - mg per 100 mcl oromucosal spray (Sativex) titrated to max 6 doses with stable dosing for further 3 weeks … , crossover to ibuprofen 400 mg/day for 8 weeks 0.5 mg/day Ibuprofen 400 mg/day for 8 weeks, crossover … , cross over to ibuprofen 400 mg/day for 8 weeks Ibuprofen 400 mg/day for 8 weeks, crossover to nabilone … , cross over to ibuprofen 400 mg/day for 8 weeks Ibuprofen 400 mg/day for 8 weeks, crossover to nabilone … , cross over to ibuprofen 400 mg/day for 8 weeks Ibuprofen 400 mg/day for 8 weeks, crossover to nabilone
-
psnet.ahrq.gov/node/49485/psn-pdf
August 29, 2024 - Two weeks later during a clinic visit, the patient complained of blindness in the left eye. … Many days to weeks later, when disc edema has usually
resolved, the funduscopic exam reveals optic nerve … patient’s blurry vision in the recovery room was related to her
subsequent blindness in one eye 2 weeks … with
significant gastrointestinal bleeding have also been reported to develop AION between 1 and 3 weeks … The finding of retinal ischemia in this patient 2 weeks postoperatively is most likely a misinterpretation
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - 19
14-16 weeks/3-4 months 8
24-26 weeks/6 months 13
10-11 months 2
48 weeks 3
1 year 7
15 … Study durations ranged from 12 weeks to 3 years, with a mean of 55 weeks (median 26
weeks). … Study durations ranged from 12 weeks to 3.3 years, with a median of 26 weeks. … Study durations
ranged from 12 weeks to 3 years, with a median of 16 weeks. … Study durations ranged from 12 weeks to 5 years, with a mean of
49 weeks (median 25 weeks).
-
www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
November 15, 2012 - A 48-week boceprevir regimen (4 weeks of dual-therapy lead-in followed by 44 weeks of triple therapy) … 48 weeks without dual-therapy lead-in, or response-guided triple therapy for 28 or 48 weeks) were associated … Two trials found no difference between 12 weeks of triple therapy and 48 weeks of dual therapy 56 , 58 … Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. … plus ribavirin, followed by the addition of boceprevir for 44 more weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
January 01, 2022 - , Median) Pain Duration, Months Psychiatric Comorbidity % N Interventions Dose Treatment Duration (Weeks … NA
CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … to -50.1 vs. -24.9 to -22.2)
LS mean difference: −27.84 (95% CI −29.71 to −25.96), p<0.001
PIX from weeks … B
Modified pain disability index, weeks 2 to 24 (95% CI −67.78 to -64.01 vs. −45.23 to −41.46), p<0.001 … B
MFHW, weeks 2 to 24: (95% CI 46.24 to 50.46 vs. 5.75 to 1.53), p<0.001
MFHW- mental component summary